Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 8106

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.29, p 0.443). This receipt's hash covers every field on it, plus the hash of receipt 8105, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 8106
    24 Oct 2026, 01:17 UTC

    RGS9

    dopamine neurons, braak

    predictionRGS9 in dopamine neurons tracks Braak Lewy-body stage

    registeredcd70dea2ca28b444

    discovery-0.29 p=0.443 n=9

    replication+0.25 p=0.514 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.29, p 0.443)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    7b3b8822ee510f81c677926f…
    follows a14cd783b13c…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 8106: RGS9 in dopamine neurons, braak

power
full sample -0.08 (p 0.741, n 18), 95% CI -0.53 to +0.40. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.09 (p 0.709, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.24 (p 0.328, n 18). could be the mix.
skeptic
leave-one-out range -0.21 to +0.03, sign flips 3; without severely affected donors -0.08 (p 0.741, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for RGS9 in dopamine neurons.

case closed: nothing better to follow up.